Mutant Breast Cancer
📧 Sign up to get email alerts when something new happens for Mutant Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-01-30Clinical Trial Update: Pyrotinib in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer [Phase 2]
Phase 2 trial update for pyrotinib in metastatic HER2 non-amplified but HER2-mutant breast cancer.